Nevirapine approved.
D000998:Antiviral Agents / Q000627:therapeutic use*; D017277:Drug Approval; D004359:Drug Therapy, Combination; D006801:Humans; D019829:Nevirapine; D011725:Pyridines / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D011725:Pyridines; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine